Clinical Trial Detail

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

NCT ID	NCT04044430
Title	Encorafenib, Binimetinib, and Nivolumab in Treating Patients With Microsatellite Stable BRAF V600E Metastatic Colorectal Cancer
Recruitment	Terminated
Gender	both
Phase	Phase Ib/II
Variant Requirements	Yes
Sponsors	University of California, San Francisco
Indications	colon adenocarcinoma rectum adenocarcinoma
Therapies	Binimetinib + Encorafenib + Nivolumab
Age Groups:	senior \| adult
Covered Countries	USA